Skip to main content

Table 2 Treatment used by the study patients with idiopathic uveitis (idio-U) or juvenile idiopathic arthritis related uveitis (JIA-U). The patients were commonly using several medications simultaneously depending on the severity of ocular inflammation. Only one bDMARDs, however, was used at a time

From: Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study

Treatment, n (%)

idio-U

JIA-U

p-value

 

n = 27

n = 92

 

Topical corticosteroids

24 (89)

92 (100)

0.036

Systemic corticosteroids

8 (30)

25 (27)

0.810

Dexamethasone implant

0 (0)

4 (3)

 

DMARDs

9 (33)

79 (85)

< 0.001

bDMARDs

4 (15)

51 (55)

< 0.001

 Adalimumab

4 (15)

44 (48)

 

 Infliximab

0 (0)

9 (8)

 

 Others

0 (0)

9 (8)

 
  1. DMARD; disease-modifying antirheumatic drug
  2. bDMARDs; biologic disease-modifying antirheumatic drug
  3. Others; etanercept (for arthritis), golimumab, tocilizumab, abatacept